Blue Sail Medical Co.,Ltd. (002382.SZ)
CNY 5.54
(-0.72%)
CNY 5.54
(-0.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.85 Billion CNY | 20.09% |
| 2022 | 3.21 Billion CNY | -13.95% |
| 2021 | 3.73 Billion CNY | -32.88% |
| 2020 | 5.55 Billion CNY | 51.09% |
| 2019 | 3.67 Billion CNY | -0.77% |
| 2018 | 3.7 Billion CNY | 5952.24% |
| 2017 | 61.25 Million CNY | 3.09% |
| 2016 | 59.42 Million CNY | -27.92% |
| 2015 | 82.44 Million CNY | -70.24% |
| 2014 | 276.98 Million CNY | -39.6% |
| 2013 | 458.54 Million CNY | 53.35% |
| 2012 | 299.02 Million CNY | 202.49% |
| 2011 | 98.85 Million CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 100 Million CNY | 25.0% |
| 2008 | 80 Million CNY | 23.08% |
| 2007 | 65 Million CNY | -23.53% |
| 2006 | 85 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 3.38 Billion CNY | -11.2% |
| 2024 Q1 | 3.98 Billion CNY | 3.22% |
| 2024 Q2 | 3.82 Billion CNY | -3.86% |
| 2023 Q3 | 3.48 Billion CNY | 1.55% |
| 2023 Q4 | 3.85 Billion CNY | 10.5% |
| 2023 Q1 | 3.11 Billion CNY | -2.97% |
| 2023 Q2 | 3.43 Billion CNY | 10.3% |
| 2023 FY | 3.85 Billion CNY | 20.09% |
| 2022 Q4 | 3.21 Billion CNY | 4.01% |
| 2022 FY | 3.21 Billion CNY | -13.95% |
| 2022 Q1 | 3.4 Billion CNY | -8.74% |
| 2022 Q2 | 2.99 Billion CNY | -12.03% |
| 2022 Q3 | 3.08 Billion CNY | 3.06% |
| 2021 Q3 | 3.85 Billion CNY | 9.66% |
| 2021 Q1 | 3.6 Billion CNY | -35.15% |
| 2021 Q2 | 3.51 Billion CNY | -2.58% |
| 2021 Q4 | 3.73 Billion CNY | -3.12% |
| 2021 FY | 3.73 Billion CNY | -32.88% |
| 2020 Q1 | 3.48 Billion CNY | -5.35% |
| 2020 Q2 | 6.71 Billion CNY | 92.96% |
| 2020 Q3 | 6.14 Billion CNY | -8.6% |
| 2020 FY | 5.55 Billion CNY | 51.09% |
| 2020 Q4 | 5.55 Billion CNY | -9.5% |
| 2019 Q1 | 3.96 Billion CNY | 6.88% |
| 2019 Q3 | 3.66 Billion CNY | 0.2% |
| 2019 Q2 | 3.65 Billion CNY | -7.75% |
| 2019 FY | 3.67 Billion CNY | -0.77% |
| 2019 Q4 | 3.67 Billion CNY | 0.44% |
| 2018 Q1 | 159.67 Million CNY | 160.67% |
| 2018 Q2 | 3.68 Billion CNY | 2210.62% |
| 2018 Q4 | 3.7 Billion CNY | -1.14% |
| 2018 Q3 | 3.75 Billion CNY | 1.64% |
| 2018 FY | 3.7 Billion CNY | 5952.24% |
| 2017 Q3 | 63.64 Million CNY | -4.91% |
| 2017 Q4 | 61.25 Million CNY | -3.76% |
| 2017 FY | 61.25 Million CNY | 3.09% |
| 2017 Q2 | 66.93 Million CNY | 123.12% |
| 2017 Q1 | 30 Million CNY | 0.0% |
| 2016 FY | 59.42 Million CNY | -27.92% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q2 | 66.31 Million CNY | 0.0% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q2 | 9.1 Million CNY | -96.16% |
| 2015 Q3 | 112.53 Million CNY | 1135.35% |
| 2015 Q4 | - CNY | -100.0% |
| 2015 Q1 | 237.43 Million CNY | -14.28% |
| 2015 FY | 82.44 Million CNY | -70.24% |
| 2014 FY | 276.98 Million CNY | -39.6% |
| 2014 Q2 | 501.57 Million CNY | 10.51% |
| 2014 Q3 | 330.06 Million CNY | -34.19% |
| 2014 Q4 | 276.98 Million CNY | -16.08% |
| 2014 Q1 | 453.88 Million CNY | -1.02% |
| 2013 FY | 458.54 Million CNY | 53.35% |
| 2013 Q4 | 458.54 Million CNY | -7.05% |
| 2013 Q3 | 493.3 Million CNY | -2.29% |
| 2013 Q2 | 504.86 Million CNY | 16.1% |
| 2013 Q1 | 434.84 Million CNY | 45.42% |
| 2012 Q1 | 196.13 Million CNY | 98.41% |
| 2012 Q2 | 244.63 Million CNY | 24.73% |
| 2012 Q3 | 230 Million CNY | -5.98% |
| 2012 Q4 | 299.02 Million CNY | 30.01% |
| 2012 FY | 299.02 Million CNY | 202.49% |
| 2011 FY | 98.85 Million CNY | 0.0% |
| 2011 Q4 | 98.85 Million CNY | 89.58% |
| 2011 Q3 | 52.14 Million CNY | 40.13% |
| 2011 Q2 | 37.2 Million CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q2 | 50 Million CNY | -50.0% |
| 2010 Q3 | - CNY | -100.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q1 | 100 Million CNY | 0.0% |
| 2009 FY | 100 Million CNY | 25.0% |
| 2009 Q2 | 85 Million CNY | 0.0% |
| 2009 Q4 | 100 Million CNY | 0.0% |
| 2008 FY | 80 Million CNY | 23.08% |
| 2007 FY | 65 Million CNY | -23.53% |
| 2006 FY | 85 Million CNY | 0.0% |